Balanced news tone
News Sentiment
DJNJ3 sentiment intelligence
Johnson & Johnson news scored across direct company coverage, industry context, sector read-through, source quality, and freshness.
Weighted score
59
Balanced news tone
11 relevant articles
News tone and price action are not far from neutral.
75/100 classification confidence.
directly relevant articles
high-authority source matches
+0.0% over one week, +0.0% over four weeks, trend inactive, and near fair-value range.
Johnson & Johnson Dividend Stock Analysis: 64 Years of Increases and Current Valuation - News and Statistics
Market Reaction
Balanced read
News tone and price action are not far from neutral.
Primary event
Market update
75/100 classification
One-week reaction
0.0%
Price digesting
Trend fit
Trend inactive
0.0% over four weeks
Fair value
-2.9%
Near fair-value range
Sentiment Mix
Positive, neutral, negative
Positive
5
Neutral
6
Negative
0
Relevance
Why the article matched
Sources
Coverage mix
Event Lens
What the news is about
Sentiment Trail
Score over time
Above 50
Neutral zone
Below 50
News Tape
Relevant headlines
IndexBox
Direct company coverage
Johnson & Johnson Dividend Stock Analysis: 64 Years of Increases and Current Valuation - News and Statistics
- Tone
- Positive 66/100
- Event
- Capital return
- Published
- 06 Jun 2026 15:10
- Source
- IndexBox
MLQ.ai
Direct company coverage
Johnson & Johnson Posts Strong Q1 2026, Raises Full-Year Guidance
- Tone
- Positive 82/100
- Event
- Guidance
- Published
- 14 Apr 2026 07:00
- Source
- MLQ.ai
Barron's
Direct company coverage
Johnson & Johnson Exits 3 Biotechs but Keeps Stakes in These Rumored Acquisition Targets
- Tone
- Neutral 50/100
- Event
- Deals and strategy
- Published
- 25 Mar 2026 07:00
- Source
- Barron's
geneonline.com
Direct company coverage
Correction Issued on March 3, 2026 Regarding Johnson & Johnson Stock Performance
- Tone
- Neutral 50/100
- Event
- Market update
- Published
- 03 Mar 2026 08:00
- Source
- geneonline.com
Proactive financial news
Direct company coverage
Johnson & Johnson reports Q4 earnings beat, issues 2026 guidance above forecasts
- Tone
- Positive 66/100
- Event
- Earnings
- Published
- 22 Jan 2026 08:00
- Source
- Proactive financial news
CHEManager
Direct company coverage
Johnson & Johnson Acquires Halda Therapeutics for $3.05 Billion
- Tone
- Neutral 50/100
- Event
- Market update
- Published
- 20 Nov 2025 08:00
- Source
- CHEManager
Law.com
Direct company coverage
Florida Jury Returns $20M Talc-Mesothelioma Verdict Against Johnson & Johnson
- Tone
- Neutral 50/100
- Event
- Market update
- Published
- 28 Oct 2025 07:00
- Source
- Law.com
Barron's
Direct company coverage
Johnson & Johnson in $14.6 Billion Deal to Buy Biotech Intra-Cellular
- Tone
- Positive 66/100
- Event
- Deals and strategy
- Published
- 13 Jan 2025 08:00
- Source
- Barron's
Market source
Direct company coverage
Why Is Johnson & Johnson (JNJ) Down 6.7% Since Last Earnings Report?
- Tone
- Neutral 50/100
- Event
- Earnings
- Published
- 14 Nov 2024 08:00
- Source
- Market source
Johnson & Johnson
Direct company coverage
Johnson & Johnson Foundation funds accelerator to support healthcare innovators in Latin America
- Tone
- Neutral 50/100
- Event
- Market update
- Published
- 10 Oct 2024 07:00
- Source
- Johnson & Johnson
Barron's
Direct company coverage
Johnson & Johnson to Buy Shockwave Medical for $13.1 Billion. It’s a Cardio Health Play.
- Tone
- Positive 66/100
- Event
- Market update
- Published
- 05 Apr 2024 07:00
- Source
- Barron's